These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 1185108

  • 1. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    Fearon DT, Austen KF.
    J Exp Med; 1975 Oct 01; 142(4):856-63. PubMed ID: 1185108
    [Abstract] [Full Text] [Related]

  • 2. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 3. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT, Austen KF.
    J Exp Med; 1977 Jul 01; 146(1):22-33. PubMed ID: 559720
    [Abstract] [Full Text] [Related]

  • 4. Control of the amplification convertase of complement by the plasma protein beta1H.
    Weiler JM, Daha MR, Austen KF, Fearon DT.
    Proc Natl Acad Sci U S A; 1976 Sep 01; 73(9):3268-72. PubMed ID: 1067618
    [Abstract] [Full Text] [Related]

  • 5. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun 01; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 6. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Jan 01; 116(1):1-7. PubMed ID: 1245733
    [Abstract] [Full Text] [Related]

  • 7. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    Schreiber RD, Medicus RG, Gïtze O, Müller-Eberhard HJ.
    J Exp Med; 1975 Sep 01; 142(3):760-72. PubMed ID: 1165475
    [Abstract] [Full Text] [Related]

  • 8. Properdin: initiation of alternative complement pathway.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1975 Aug 01; 72(8):3220-4. PubMed ID: 1059108
    [Abstract] [Full Text] [Related]

  • 9. The natural modulation of the amplification phase of complement activation.
    Fearon DT, Daha MR, Weiler JM, Austen KF.
    Transplant Rev; 1976 Aug 01; 32():12-25. PubMed ID: 62426
    [Abstract] [Full Text] [Related]

  • 10. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Aug 01; 117(2):630-4. PubMed ID: 950465
    [Abstract] [Full Text] [Related]

  • 11. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1977 Apr 01; 74(4):1683-7. PubMed ID: 266208
    [Abstract] [Full Text] [Related]

  • 12. A molecular concept of the properdin pathway.
    Medicus RG, Schreiber RD, Götze O, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1976 Feb 01; 73(2):612-6. PubMed ID: 54923
    [Abstract] [Full Text] [Related]

  • 13. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May 01; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the alternative complement pathways by beta 1 H globulin.
    Whaley K, Ruddy S.
    J Exp Med; 1976 Nov 02; 144(5):1147-63. PubMed ID: 62817
    [Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of Guinea pig properidin.
    Nicholson A, Austen KF.
    J Immunol; 1977 Jan 02; 118(1):103-8. PubMed ID: 830742
    [Abstract] [Full Text] [Related]

  • 16. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
    Takahashi M, Tack BF, Nussenzweig V.
    J Exp Med; 1977 Jan 01; 145(1):86-100. PubMed ID: 830792
    [Abstract] [Full Text] [Related]

  • 17. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1062-75. PubMed ID: 62010
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1979 Nov 01; 76(11):5867-71. PubMed ID: 293688
    [Abstract] [Full Text] [Related]

  • 19. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL, Peng C, Kostavasili I, Friedman HM, Lambris JD, Eisenberg RJ, Cohen GH.
    Virology; 1994 Sep 01; 203(2):299-312. PubMed ID: 8053154
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC, Lachmann PJ, Harrison RA.
    Biochem J; 1988 May 15; 252(1):47-54. PubMed ID: 3421908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.